Orphan Drugs “ Empowering Hope : Bridging Gaps With Orphan Drugs ’’.
Main Article Content
Abstract
- “The Orphan Drug Designation program assigns orphan designation to medicines and biologics that are designed for the safe and effective treatment, diagnosis, or prevention of uncommon diseases/disorders.
- THE SO-CALLED “ORPHAN DRUGS” ARE MEANT TO CURE ILLNESSES THAT ARE SO UNCOMMON THAT THEIR SPONSORSARE HESITANT TO PURSUE THEM UNDER NORMAL COMMERCIALIZATION GUIDELINES.
- THE DEMAND FOR ECONOMIC FEASIBILITY PREVENTS EVEN PRIORITIES OF RESEARCH INTO THESE DISORDERS.
- THEY WERE DEVELOPED IN REACTION TO PUBLIC HEALTH NEEDS, NOT BY THE PHARMACEUTICAL INDUSTRY FOR ECONOMIC REASONS.
- Developing orphan drugs is a significant challenge for pharmaceutical companies.
Downloads
Download data is not yet available.
Article Details
How to Cite
M.sreeVidhya, Dr. E. Karthikeyan, Nirogi Sri vidya, Kandi Subhashini, Sowjanya Lakshmi, & Suchitra Sri Bhargavi. (2024). Orphan Drugs “ Empowering Hope : Bridging Gaps With Orphan Drugs ’’. Educational Administration: Theory and Practice, 30(4), 4493–4502. https://doi.org/10.53555/kuey.v30i4.2240
Section
Articles